AFLAC Incorporated · NYSE:AFL

AFLAC — Investor Presentation (June 2020)

24 slides from AFLAC's investor presentation, June 2020

  1. Slide 1: Investor Presentation

    Investor Presentation June 2020 investors.aflac.com

  2. Slide 2: Forward-Looking Statements and Non-U.S.GAAP Financial Measures

    Forward-Looking Statements and Non-U.S.GAAP Financial Measures The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by m

  3. Slide 3: Aflac Incorporated: Leading Supplemental Insurer

    Aflac Incorporated: Leading Supplemental Insurer Aflac Incorporated through its subsidiaries is the leading supplemental insurer in the U.S. and Japan providing a layer of financial protection due to a medical event or critical illness, such as cancer, to more than 50 million people 2019 Adjusted Re

  4. Slide 4: Aflac Incorporated: Organizational Structure

    Aflac Incorporated: Organizational Structure 1 Aflac Incorporated Aflac Holdings American Continental Tier One Aflac Dental LLC Family Life American Aflac Asset Aflac Aflac Global Insurance & Vision Assurance Insurance Management International Ventures Company (Argus) Aflac Life Company Company Insu

  5. Slide 5: Aflac Incorporated's Strategic Points of Leverage

    Aflac Incorporated’s Strategic Points of Leverage • Recognized and powerful brand • Diverse and productive distribution • Product innovation and customized, high-quality service • Leading market share and scale in Japan and U.S. • Industry-leading financial strength ratings » Strong capital & liquid

  6. Slide 6: Aflac Incorporated's Long-Term Growth Strategy

    Aflac Incorporated's Long-Term Growth Strategy 6

  7. Slide 7: Aflac U.S. Overview

    Aflac U.S. Overview Business Profile 2019 Net Earned Premium  Aflac is the # 1 provider of supplemental insurance at the worksite in the U.S.1  96% of Aflac U.S. Individual and Group sales occur via payroll deduction Cancer  Aflac’s supplemental policies pay cash directly to the insured to help p

  8. Slide 8: Aflac Japan Overview

    Aflac Japan Overview Business Profile 2019 U.S. GAAP Net Earned Premium  In 1974, Aflac pioneered cancer insurance in Japan and launched a standalone whole life medical policy in 2002  Today, our core third sector insurance – cancer and medical – helps policyholders cover out-of-pocket expenses Me

  9. Slide 9: Financial Drivers

    Financial Drivers Strong and stable profit margins Stable investment income with tactical approach to Japan's USD portfolio Strength in cash flow and balanced capital deployment Underpinned by Economic Value and Risk Management 9

  10. Slide 10: 1Q20 Financial Position versus 1Q19

    1Q20 Financial Position versus 1Q191 Entering the crisis with strength and capacity in margins, capital and liquidity Aflac U.S. Aflac Japan Aflac Japan SMR (%) 1,200 1043 961 Benefit 3rd Sector 881 Ratio Benefit Ratio 800 48.1% 59.0% -120 bps 60 bps 400 0 Mar. 2019 Dec. 2019 Mar. 2020 Adj. Expense

  11. Slide 11: Continued Strength in Core Benefit Ratios

    Continued Strength in Core Benefit Ratios COVID-19 in early stages with little claims impact 2020 Benefit 1Q20 2020 Benefit 1Q20 Ratio Outlook Benefit Ratio Ratio Outlook Benefit Ratio 68.0 to 70.0% 69.4% 49.0 to 51.0% 48.1% Aflac Japan Aflac U.S. • ¥1.8 million in 1Q20 COVID-19 claims • No material

  12. Slide 12: COVID-19 Claims Sensitivity

    COVID-19 Claims Sensitivity Stress-Testing Positions Aflac to Protect the Following: • The promises we make to our policyholders when they need us most • Our strong insurance financial strength ratings and access to capital • Preserving our strong regulatory standing with transparent communication •

  13. Slide 13: Proactive De-Risking Has Defensively Positioned Our Portfolio

    Proactive De-Risking Has Defensively Positioned Our Portfolio Strategic asset allocation, greater diversification and capital efficiency Cumulative De-risking Fixed Maturities BBB and Fallen Angel Exposure1 $8.5 Total BBB BBB- (included in Total BBB) Fallen Angels 9.0 Cumulative De-risking ($bn) 45.

  14. Slide 14: Consolidated Portfolio Overview

    Consolidated Portfolio Overview 1 Asset Allocation Quality5 AUM: $123 billion Avg. Credit Quality: A 42.8% Over 94% of rated securities are SAA goal of diversification Investment Grade 47.5% 15.6% 17.3% 25% 11.3% 7.8% 7.2% 8.4% 10.1% 9.2% 4.1% 5.7% 5.5% 1.0% 1.1% 0.6% 1.2% 2.6% JGB Yen Private Yen P

  15. Slide 15: Portfolio Stress Test Under Global Recession Assumptions

    Portfolio Stress Test Under Global Recession Assumptions Vulnerable Total Sector Vulnerable Stress Case Loss Comments Sectors AUM Exposures Potential % of Fixed Maturities Fixed Maturities ($bn) ($bn) AUM1 75% in less volatile sub-sectors Energy $5.0 $2.2 0.40% Watching ~25% in Independent and Servi

  16. Slide 16: 1Q20 Insurance Capital Position

    1Q20 Insurance Capital Position Aflac enters the pandemic with strong core insurance capital ratios Japan SMR volatility in Q1 driven by credit spreads and foreign exchange Aflac Japan SMR (%) Aflac - Columbus RBC (%) 1,200 800 Capital 1043 draw down 961 881 704 600 800 539 400 >550 400 200 0 0 Mar.

  17. Slide 17: Reinforced Strong Capital and Liquidity

    Reinforced Strong Capital and Liquidity Remaining tactical and supporting ratings and growth Proactive Measures to Bolster Liquidity and Capital Liquidity • $4.8 billion of cash at the holding company1, including: • $1.5 billion of recent senior unsecured debt issuance optimizing yen and dollar fina

  18. Slide 18: Aflac Ventures Fund Summary

    Aflac Ventures Fund Summary1 Total Fund Investment by Region Investment by Type 19% 26% $400 $156.2 46% 59% 41% 61% Million Million 13% 35% Investment $103.5 26% Japan $30.1 19% External Fund $63.9 41% Additional Committed $52.6 13% U.S. $55.1 35% Direct $92.2 59% Remaining funds $243.8 61% Global $

  19. Slide 19: Appendix

    Appendix

  20. Slide 20: Definitions of Non-U.S. GAAP Financial Measures

    Definitions of Non-U.S. GAAP Financial Measures Aflac defines the non-U.S. GAAP measures included in this presentation as follows: • The Company defines adjusted earnings as the profits derived from operations. The most comparable U.S. GAAP measure is net earnings. Adjusted earnings are adjusted rev

  21. Slide 21: 1Q20 Financial Position

    1Q20 Financial Position1 Benefit ratios and pretax profit margins provide capacity to absorb elevated losses Aflac Incorporated 1Q20 Δ yoy Aflac Japan 1Q20 Δ yoy Net EPS $0.78 -36.6% Total Net Premiums ¥343.1 bn -2.1% Adjusted EPS* $1.21 8.0% Net Investment Income 75.9 bn 2.5% Adjusted EPS ex-FX* $1

  22. Slide 22: Reconciliation of Net Earnings to Adjusted Earnings per Share

    Reconciliation of Net Earnings to Adjusted Earnings per Share1 (Three Months Ended March 31) 2020 2019 % Inc. Net earnings per diluted share $ 0.78 $1.23 (36.6)% Items impacting net earnings: Net investment (gains) losses 0.62 (0.14) Other and non-recurring (income) loss 0.02 ̶ Income tax (benefit)

  23. Slide 23: Reconciliation of U.S. GAAP Return on Equity to Adjust ROE

    Reconciliation of U.S. GAAP Return on Equity to Adjust ROE1 (Three Months Ended March 31) 2020 2019 Net earnings – U.S. GAAP ROE2 8.2% 15.0% Impact of excluding unrealized foreign currency translation gains (losses) (0.6) (1.3) Impact of excluding unrealized gains (losses) on securities and derivati

  24. Slide 24: Reconciliation of U.S. GAAP Book Value per Share

    Reconciliation of U.S. GAAP Book Value per Share1 (Three Months Ended March 31, In Millions of Dollars) 2020 2019 % Inc. U.S. GAAP book value $ 26,402 $ 26,049 Less: Unrealized foreign currency translation gains (losses) (1,543) (1,848) Unrealized gains (losses) on securities and derivatives 6,008 6

Aflac — Investor Presentation (June 2020) on 6ix